title: Can regenerative medicine save Big Pharma&#x2019;s business model from the patent cliff?
authors.forename: Alexander
authors.initials: A
authors.lastname: Denoon
authors.forename: Erik
authors.initials: E
authors.lastname: Vollebregt
mesh_terms: D003132:Commerce; D010330:Patents as Topic; D044968:Regenerative Medicine / Q000331:legislation & jurisprudence / Q000379:methods*